<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have identified desmoglein-2 (DSG-2) as the primary high-affinity receptor used by adenoviruses Ad3, Ad7, Ad11 and Ad14 </plain></SENT>
<SENT sid="1" pm="."><plain>These serotypes represent key human pathogens causing respiratory and <z:hpo ids='HP_0000010'>urinary tract infections</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In epithelial cells, adenovirus binding of DSG-2 triggers events reminiscent of epithelial-to-mesenchymal transition, leading to transient opening of intercellular junctions </plain></SENT>
<SENT sid="3" pm="."><plain>This opening improves access to receptors, for example, CD46 and Her2/neu, that are trapped in intercellular junctions </plain></SENT>
<SENT sid="4" pm="."><plain>In addition to complete virions, dodecahedral particles (PtDds), formed by excess amounts of <z:mp ids='MP_0001799'>viral</z:mp> capsid proteins, penton base and fiber during <z:mp ids='MP_0001799'>viral</z:mp> replication, can trigger DSG-2-mediated opening of intercellular junctions as shown by studies with recombinant Ad3 PtDds </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings shed light on adenovirus biology and pathogenesis and may have implications for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
</text></document>